These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12754271)

  • 1. Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells.
    Davis J; Wagner MR; Zhang W; Xu F; Van Nostrand WE
    J Biol Chem; 2003 May; 278(21):19054-61. PubMed ID: 12754271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
    Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells.
    Jung SS; Zhang W; Van Nostrand WE
    J Neurochem; 2003 Jun; 85(5):1208-15. PubMed ID: 12753080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells.
    Previti ML; Zhang W; Van Nostrand WE
    J Neuroinflammation; 2006 Aug; 3():18. PubMed ID: 16887032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
    Lugano R; Peña E; Badimon L; Padró T
    J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall.
    Van Nostrand WE; Melchor J; Wagner M; Davis J
    Ann N Y Acad Sci; 2000 Apr; 903():89-96. PubMed ID: 10818493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells.
    Melchor JP; Van Nostrand WE
    J Biol Chem; 2000 Mar; 275(13):9782-91. PubMed ID: 10734132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
    Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
    J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells.
    Van Nostrand WE; Melchor JP
    Amyloid; 2001 Jul; 8 Suppl 1():20-7. PubMed ID: 11676286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein.
    Melchor JP; McVoy L; Van Nostrand WE
    J Neurochem; 2000 May; 74(5):2209-12. PubMed ID: 10800967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    Diaz A; Martin-Jimenez C; Woo Y; Merino P; Torre E; Yepes M
    J Alzheimers Dis; 2022; 89(3):877-891. PubMed ID: 35964187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
    Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
    Iwamoto J; Takahashi K; Mizokami Y; Otsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokoube K; Matsuoka T
    Dig Dis Sci; 2003 Dec; 48(12):2247-56. PubMed ID: 14714609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented urokinase receptor expression in atheroma.
    Noda-Heiny H; Daugherty A; Sobel BE
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):37-43. PubMed ID: 7749814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.
    Roelofs JJ; Rowshani AT; van den Berg JG; Claessen N; Aten J; ten Berge IJ; Weening JJ; Florquin S
    Kidney Int; 2003 Nov; 64(5):1845-53. PubMed ID: 14531820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity.
    Jung SS; Van Nostrand WE
    J Neurochem; 2003 Jan; 84(2):266-72. PubMed ID: 12558989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.